Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

596
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
596
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

93
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
93
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

312
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

99
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
99
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

125
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
125

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of economic sanctions on child health in Cuba.

BMJ paediatrics open·2026
Same author

Impact of hospital payment reform on rational use of antibiotics: a natural experiment.

Frontiers in public health·2025
Same author

Profiting from death: the arms trade.

BMJ paediatrics open·2025
Same author

Advertising and child health.

BMJ paediatrics open·2025
Same author

Patient-reported outcome measures for medication treatment satisfaction: a systematic review of measure development and measurement properties.

BMC medicine·2024
Same author

Global, regional and national availability of essential medicines for children, 2009-2020: a systematic review and meta-analysis.

BMC public health·2023

Related Experiment Video

Updated: Mar 16, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

10.2K

LONG-COURSE ORAL CORTICOSTEROID TOXICITY IN CHILDREN.

Fahad Aljebab1, Imti Choonara1, Sharon Conroy1

  • 1University of Nottingham.

Archives of Disease in Childhood
|August 20, 2016
PubMed
Summary

Long-term oral corticosteroids in children frequently cause weight gain, Cushingoid features, and growth issues. Increased susceptibility to infection is the most serious adverse drug reaction, leading to mortality.

Area of Science:

  • Pediatric pharmacology
  • Drug safety
  • Systematic reviews

Background:

  • Oral corticosteroids are widely used for pediatric conditions like nephrotic syndrome, leukemia, and asthma.
  • Adverse drug reactions (ADRs) are a known concern with prolonged corticosteroid use in children.
  • This review systematically identifies common and serious ADRs and their risk levels.

Purpose of the Study:

  • To identify the most frequent and serious adverse drug reactions (ADRs) associated with long-term oral corticosteroid use in children.
  • To determine the relative risk levels of these identified ADRs.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (Embase, Medline, PubMed, etc.) up to March 2014.
  • Studies included pediatric patients (28 days to 18 years) treated with corticosteroids for at least 15 days.
Keywords:
AbstractOral

More Related Videos

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.9K
Adult Zebrafish Injury Models to Study the Effects of Prednisolone in Regenerating Bone Tissue
07:38

Adult Zebrafish Injury Models to Study the Effects of Prednisolone in Regenerating Bone Tissue

Published on: October 18, 2018

9.4K

Related Experiment Videos

Last Updated: Mar 16, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

10.2K
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.9K
Adult Zebrafish Injury Models to Study the Effects of Prednisolone in Regenerating Bone Tissue
07:38

Adult Zebrafish Injury Models to Study the Effects of Prednisolone in Regenerating Bone Tissue

Published on: October 18, 2018

9.4K
  • All study types reporting clear ADR information were included.

    • Main Results:

    • 91 studies involving 6653 children reported 4124 ADRs, primarily in leukemia, hemangioma, and asthma patients.
    • Oral prednisolone was the most common corticosteroid (74%).
    • Frequent ADRs included weight gain (22.4%), Cushingoid features (20.6%), and growth retardation (18.9%). Increased susceptibility to infection was the most serious ADR, causing 24 deaths.

    Conclusions:

    • Weight gain, Cushingoid features, and growth retardation are the most common adverse drug reactions from long-term oral corticosteroid therapy in children.
    • Increased susceptibility to infection represents the most significant cause of mortality in this patient group.